15.52 -0.31 (-1.96%)
Pre-market: 8:17AM EST
|Bid||15.61 x 1200|
|Ask||15.65 x 800|
|Day's range||15.19 - 16.62|
|52-week range||15.19 - 52.74|
|Beta (3Y monthly)||4.11|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Ask Benjamin Witte about Recess, and one of the first places he’ll send you is the company’s Instagram page.
The S&P 500 edged up to a record closing high at the end of a choppy day of trading. The Dow was off just slightly as declines in shares of Cisco weighed on the 30-stock index.
Pomerantz LLP is investigating claims on behalf of investors of Canopy Growth Corporation (“Canopy” or the “Company”) (NYSE: CGC). Such investors are advised to contact Robert S. Willoughby at email@example.com or 888-476-6529, ext. The investigation concerns whether Canopy and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
Canopy Growth Corporation (CGC) delivered earnings and revenue surprises of -203.70% and -24.73%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
(Bloomberg) -- Canopy Growth Corp. shares fell to the lowest in nearly two years after the pot company reported revenue that missed the lowest analyst estimate and a loss that one analyst called “astounding.”The world’s largest cannabis company by market value also said it’s unlikely to meet its previous guidance of C$250 million ($189 million) in revenue by the fiscal fourth quarter, which ends March 31.Shares fell as much as 18% Thursday to C$20.15, the lowest since December 2017. The stock has lost more than 70% since its recent highs in April amid broad-based pressure on the cannabis sector. Investors are growing increasingly impatient with companies that don’t show a clear path to profitability, and other factors ranging from a vaping-related health crisis to regulatory concerns are also weighing on shares.Chief Executive Officer Mark Zekulin said the company is still on track to achieve its other targets, including positive adjusted earnings before interest, taxes, depreciation and amortization in Canada by fiscal 2021, and full profitability in three to five years.Its expectation for gross margins above 40% by the end of the current fiscal year is “under pressure” but still “achievable,” Zekulin said in a phone interview Thursday.“There are several known factors causing the market problems,” he said. “As quickly as we see those get resolved, then the quicker we can get back on track for that C$250 million, whether it’s a month late or a quarter late, and see all the other things follow suit.”Canopy took a restructuring charge of C$32.7 million for returns, return provisions and pricing allowances in the quarter. These are primarily related to its portfolio of softgel and oil products, which haven’t been selling as well as expected. It also took an inventory charge of C$15.9 million to align its portfolio with a new retailing strategy.“We do not consider this type of adjustment to be one-time, as it reflects returns and new pricing architecture and package assortment going forward,” Bill Kirk, analyst at MKM Partners, said in a note. He called the magnitude of the Ebitda loss “astounding,” and said Canopy’s “excessive equity comp policy” was responsible for much of it.However, Zekulin said he’s confident the charges are one-time items.Overall, Canopy reported fiscal second-quarter net revenue of C$76.6 million, well below the consensus estimate of C$102.3 million, and an Ebitda loss of C$155.7 million. Analysts had expected an Ebitda loss of C$96.1 million.The company is searching for a new leader after co-CEO Bruce Linton was fired in July, and Zekulin said he’d step down once a replacement is found. The company has narrowed down its shortlist of candidates to a number “you can count on one hand,” Zekulin said, and hopes to make an announcement before the end of 2019.(Updates to add CEO comments in paragraphs 4-6, 9, 11)To contact the reporter on this story: Kristine Owram in New York at firstname.lastname@example.orgTo contact the editors responsible for this story: Brad Olesen at email@example.com, Courtney Dentch, Divya BaljiFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.
All eyes will be on President Trump Tuesday for U.S.-China trade war updates. Walmart, Nvidia, and others are set to report their quarterly earnings. And why Casey's General Stores (CASY) is a Zacks Rank 1 (Strong Buy) right now...
Canopy Growth (CGC) acquires a number of European companies to expand its production base across a region that promises great opportunities.
Helmerich & Payne's (HP) much popular technologically-advanced FlexRigs with strong daily rate margins might reflect on segmental profits in the to-be-reported results.
A series of acquisitions is expected to have significantly contributed to Canopy Growth's (CGC) top line in the fiscal second quarter.
Solid prospects in the Canadian and international markets are expected to have driven Aurora Cannabis' (ACB) fiscal first-quarter performance.
The latest U.S.-China trade war news that could see the world's two largest economies roll back tariffs. Q3 earnings results from the likes of Qualcomm and Square. And why Yeti is a Zacks Rank 1 (Strong Buy) stock...
Canopy Growth Corporation (CGC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
After parting ways with Canadian cannabis giant Canopy Growth, Bruce Linton is joining the board of U.S. multi-state operator Vireo Health.
Should investors think about buying some shares of Cronos (CRON) ahead of earnings, as a bet on a marijuana market comeback?
Aphria’s stock price has risen 8.9% since reporting its Q1 earnings on October 15. The cannabis sector's weakness offset some of these gains.
Cannabis company Cronos Group has expanded its presence in the US cannabidiol market through a tie-up with tobacco company Altria Group.
Canopy Growth (CGC) (WEED) and Cronos Group (CRON) are set to release their earnings next week. The cannabis sector has been on a roller coaster this year.
Today we highlighted 4 'cheap' stocks that are currently trading for under $10 per share that also sport a Zacks Rank 2 (Buy) or better that investors might want to consider buying right now...
In the latest trading session, Canopy Growth Corporation (CGC) closed at $19.86, marking a -1.44% move from the previous day.
Cantor Fitzgerald initiated coverage of six cannabis companies on Monday. Analyst Pablo Zuanic noted that several cannabis stocks have bottomed out.